Today: 7 February 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

InflaRx (IFRX) pops on positive INF904 Phase 2a results in HS & CSU; Q3 filing shows €44.4M liquidity and runway into 2027 — Nov 10, 2025

InflaRx (IFRX) pops on positive INF904 Phase 2a results in HS & CSU; Q3 filing shows €44.4M liquidity and runway into 2027 — Nov 10, 2025

InflaRx N.V. (NASDAQ: IFRX) surged into today’s session after unveiling topline Phase 2a data for its oral C5aR inhibitor INF904 in hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU), alongside filing its third‑quarter Form 6‑K showing €44.4 million of available funds and a cash runway into 2027. The company also set out next steps: a Phase 2b HS trial targeted to start in 2026 and continued partnering discussions to accelerate development across indications. What InflaRx reported today The numbers investors will care about (Q3 2025 6‑K) Why this matters Market reaction (Nov 10, 2025) Key data points from the press
10 November 2025
Rumble (RUM) soars on $767M Northern Data deal; Tether pledges up to $250M; Q3 revenue misses — Nov. 10, 2025

Rumble (RUM) soars on $767M Northern Data deal; Tether pledges up to $250M; Q3 revenue misses — Nov. 10, 2025

Rumble Inc. (NASDAQ: RUM) said today it will acquire German AI infrastructure firm Northern Data in an all‑stock transaction valued at roughly $767 million, unveiled two new commercial commitments from Tether worth up to $250 million, and released mixed Q3 2025 results. Shares initially jumped in early trading. What Rumble announced today Why it matters: The package signals Rumble’s pivot from a pure video platform toward AI and cloud infrastructure, aiming to control compute supply, reduce dependence on third‑party hyperscalers, and open new B2B revenue streams. Deal terms at a glance Q3 2025 results: revenue soft, losses narrower Rumble’s Q3
10 November 2025
···
Tesla (TSLA) News Today — November 10, 2025: China Sales Hit 3‑Year Low, Cybertruck Chief Exits, and Tesla Launches Short‑Term Rentals

Tesla (TSLA) News Today — November 10, 2025: China Sales Hit 3‑Year Low, Cybertruck Chief Exits, and Tesla Launches Short‑Term Rentals

China: sales slide underscores a tougher competitive landscape Fresh data out of Beijing show Tesla’s October retail sales fell 35.8% year over year to 26,006 vehicles, the company’s weakest monthly retail tally in three years. While exports from Giga Shanghai hit a two‑year high (35,491 units), Tesla’s domestic EV market share plunged to 3.2%, down from 8.7% in September—its lowest in more than three years. The drop comes amid fierce local competition (including Xiaomi’s record month) and softer consumer sentiment as incentives fade. Reuters Why it matters: China is Tesla’s second‑largest market; a sustained share decline can pressure margins and
10 November 2025
NVIDIA (NVDA) News Today: Stock Edges Higher as Santa Clara Data Centers Await Power; New ‘Dynamo’ AI Inference Integrations — Nov. 10, 2025

NVIDIA (NVDA) News Today: Stock Edges Higher as Santa Clara Data Centers Await Power; New ‘Dynamo’ AI Inference Integrations — Nov. 10, 2025

Market move: NVDA steadies into the open NVIDIA shares were modestly higher in early U.S. trading Monday as the market digests infrastructure headlines and platform updates ahead of next week’s earnings. Bloomberg flagged NVDA among premarket movers, and the live quote above shows spot pricing as of mid‑morning UTC. Bloomberg Infrastructure squeeze at home: Santa Clara power delays Reporting from Bloomberg and Bloomberg Law says two large data center campuses in Santa Clara, California—NVIDIA’s backyard—could sit empty for years because the municipal utility isn’t ready to deliver enough electricity. Fortune echoed the theme, underscoring how AI’s energy appetite is outpacing
10 November 2025
···
Conduent Stock Plunges 24% After Q3 Miss and Revenue Guidance Cut—Analysts Still See Upside (Nov. 10, 2025)

Conduent Stock Plunges 24% After Q3 Miss and Revenue Guidance Cut—Analysts Still See Upside (Nov. 10, 2025)

Conduent (CNDT) shares are in focus after a brutal post‑earnings slide. Coverage today highlights a roughly 24–25% drop tied to a weaker‑than‑expected Q3 and a cut to full‑year 2025 revenue guidance, deepening investor concerns about the turnaround. Yahoo Finance Key takeaways at a glance What happened: Q3 in detail Conduent’s third‑quarter 2025 print fell short of Street expectations and showed continued year‑over‑year revenue pressure: These figures come directly from the company’s Q3 release. Conduent+1 Why the guidance cut matters Management’s FY 2025 outlook now points to $3.05B–$3.10B in adjusted revenue and 5.0%–5.5% adjusted EBITDA margins—signaling a slower growth trajectory and
10 November 2025
·
Barrick Mining (B) Hikes Dividend 25% and Adds $500M Buyback as Record Q3 Cash Flow Lifts Shares

Barrick Mining (B) Hikes Dividend 25% and Adds $500M Buyback as Record Q3 Cash Flow Lifts Shares

Barrick Mining (NYSE: B; TSX: ABX) raised its base dividend 25% to $0.125 and expanded its buyback by $500M after record Q3 cash flow; shares rose premarket. TORONTO — Barrick Mining Corporation (NYSE: B; TSX: ABX) unveiled a bigger shareholder‑returns package on Monday, increasing its base quarterly dividend by 25% and authorizing an additional $500 million for share repurchases after delivering record operating and free cash flow in the third quarter of 2025. The stock traded about 3%–4% higher premarket following the release. MarketWatch+3barrick.com+3barrick.com+3 What happened Barrick reported Q3 net earnings of $1.3 billion ($0.76 per share) and adjusted EPS
10 November 2025
····
Tyson Foods (TSN) beats Q4 estimates, lifts FY26 outlook as chicken strength offsets beef headwinds — stock up on Nov. 10, 2025

Tyson Foods (TSN) beats Q4 estimates, lifts FY26 outlook as chicken strength offsets beef headwinds — stock up on Nov. 10, 2025

What Tyson reported today (Q4 & FY2025) Tyson Foods posted fiscal Q4 2025 adjusted EPS of $1.15, topping consensus, on $13.86 billion in revenue. GAAP EPS was $0.13 as the quarter included $355 million in legal contingency accruals recognized as a reduction to sales. For the full fiscal year 2025, sales reached $54.44 billion (+2.1% YoY), adjusted operating income was $2.287 billion (+26% YoY), and adjusted EPS was $4.12 (+33% YoY). Management also highlighted free cash flow of $1.18 billion, a $957 million reduction in total debt, and year‑end liquidity of $3.7 billion. Times Union+1 Segment snapshots (FY2025, adjusted operating
10 November 2025
·
Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health, Inc. (NYSE: OSCR) announced new individual-market plans for South Florida ahead of the 2026 Open Enrollment window and spotlighted HelloMeno, a menopause-focused offering it and partner Elektra Health describe as the first plan of its kind in the individual market. The rollout lands as Washington headlines around ACA premium tax credits pressure managed-care shares broadly; investors are watching OSCR’s intraday action closely. Business Wire+2PR Newswire+2 Key takeaways What Oscar announced today Oscar said it will offer new, affordable individual‑market plans across South Florida for plan year 2026, with options available in Miami‑Dade, Broward, Palm Beach, Martin, and St.
10 November 2025
·
Pagaya Technologies (PGY) posts record Q3 2025, raises full‑year guidance to $1.30–$1.325B; shares climb in early trade — Nov. 10, 2025

Pagaya Technologies (PGY) posts record Q3 2025, raises full‑year guidance to $1.30–$1.325B; shares climb in early trade — Nov. 10, 2025

Pagaya Technologies Ltd. reported record third‑quarter results and lifted its 2025 outlook before today’s earnings call, citing broad‑based growth across personal loans, auto, and point‑of‑sale financing. The company also outlined a stronger funding posture heading into year‑end. Business Wire Key numbers (Q3 2025) A detailed 8‑K filed today adds the unaudited P&L, including $80.0M in GAAP operating income for Q3 and line‑item breakdowns. SEC Guidance raised; Q4 outlook set What’s driving the upgrade Management highlighted a mix of volume growth and improved unit economics, particularly in Auto and Point‑of‑Sale (POS), alongside operating leverage as FRLPC scales faster than volume. The
10 November 2025
Plug Power (PLUG) unveils $275M liquidity plan, pivots to data‑center backup power, pauses DOE loan efforts — stock pops ahead of Q3 results (Nov. 10, 2025)

Plug Power (PLUG) unveils $275M liquidity plan, pivots to data‑center backup power, pauses DOE loan efforts — stock pops ahead of Q3 results (Nov. 10, 2025)

Plug Power Inc. (NASDAQ: PLUG) said this morning it expects to unlock more than $275 million in near‑term liquidity by monetizing certain assets and cutting operating costs—and, notably, by pursuing a non‑binding LOI to monetize electricity rights in New York and another U.S. location while collaborating with a domestic data‑center developer on hydrogen fuel‑cell backup and auxiliary power. The company also paused its activities related to the U.S. Department of Energy (DOE) loan program, redirecting capital to faster‑payback opportunities. Shares rose in pre‑market trading following the announcement. Plug Power+1 Key takeaways What happened In a press release before the open,
10 November 2025
·
Galecto (GLTO) Soars on Damora Therapeutics Acquisition and $285M Financing: IND in 2026, Proof‑of‑Concept in 2027

Galecto (GLTO) Soars on Damora Therapeutics Acquisition and $285M Financing: IND in 2026, Proof‑of‑Concept in 2027

Galecto, Inc. (NASDAQ: GLTO) said this morning it completed the acquisition of Damora Therapeutics and closed a $284.9 million oversubscribed private placement, a one‑two punch that instantly refocuses the company on mutant calreticulin (mutCALR) therapies for myeloproliferative neoplasms (MPNs) and extends its cash runway into 2029. The announcement sent GLTO screaming higher in pre‑market trading. GlobeNewswire Key takeaways Why this matters for patients and investors Damora’s approach is aimed squarely at mutant calreticulin (mutCALR)—a well‑validated genetic driver in segments of essential thrombocythemia (ET) and myelofibrosis (MF). Targeting this neoantigen has attracted growing interest as researchers seek more disease‑modifying options beyond
10 November 2025
··
XRP Pops as DTCC Lists Five Spot ETFs—But Bearish Signals Linger: Whales Return, Volatility Rises (Nov. 10, 2025)

XRP Pops as DTCC Lists Five Spot ETFs—But Bearish Signals Linger: Whales Return, Volatility Rises (Nov. 10, 2025)

What happened today ETF momentum hit the tape: The Depository Trust & Clearing Corporation (DTCC) listed five spot XRP ETFs on its site, while issuers including Bitwise, Franklin Templeton, 21Shares and Canary Capital filed amended S‑1s with standardized language. Traders read this as pre‑launch prep—especially now that the SEC has adopted generic listing standards that make spot‑crypto ETF approvals faster than the old case‑by‑case process. XRP spiked on the headline, adding ~6–8% by mid‑session. CoinDesk+2Reuters+2 Price & tape: Real‑time dashboards and major outlets pegged XRP in the $2.50–$2.55 band today after the pop, with coverage noting a 7%+ daily gain
10 November 2025
·
Beyond Meat (BYND) Today: Q3 2025 Results Expected, SEC Filing Delay Lingers After ‘Material Weakness’ Warning (Nov. 10, 2025)

Beyond Meat (BYND) Today: Q3 2025 Results Expected, SEC Filing Delay Lingers After ‘Material Weakness’ Warning (Nov. 10, 2025)

Beyond Meat is slated to report Q3 2025 results today while its 10‑Q filing slips after a “material weakness” disclosure. Here’s what to watch in BYND stock. What happened today Beyond Meat says the Q3 earnings release is slated for Monday, Nov. 10—one day earlier than previously indicated—with the earnings call still scheduled for Tuesday, Nov. 11 at 5:00 p.m. ET. Management cited the U.S. Veterans Day holiday (SEC closed) for the date shuffle. Nasdaq Separately, the formal 10‑Q is running late. On Nov. 7, Beyond Meat filed a Form NT 10‑Q and disclosed it expects to report a “material
10 November 2025
·
Dow, S&P 500, Nasdaq Futures Jump as Senate Vote Lifts Hopes for Ending 40‑Day U.S. Government Shutdown

Dow, S&P 500, Nasdaq Futures Jump as Senate Vote Lifts Hopes for Ending 40‑Day U.S. Government Shutdown

U.S. equity futures rose Monday after a procedural Senate vote advanced a funding bill that could reopen the federal government as soon as this week. The rebound followed last week’s tech-led selloff, with AI and semiconductor names leading premarket gains. Global stocks rallied, Treasury yields climbed, and volatility eased. Reuters+1 What changed in Washington — and why markets care Late Sunday, the Senate advanced a House-passed measure that lawmakers plan to amend to fund the government through January 30 alongside three full‑year appropriations bills. The package would still need final Senate passage, approval by the House, and President Donald Trump’s
10 November 2025
Nov. 10, 2025 — Alabama Power’s bills under the microscope as Veterans find healing with horses ahead of Veterans Day

Nov. 10, 2025 — Alabama Power’s bills under the microscope as Veterans find healing with horses ahead of Veterans Day

What’s new today Mobile County public hearing (10 a.m.) — The Mobile County Commission will take public comment on a proposed expansion of the Chastang Landfill’s service area and daily intake. The hearing begins at 10 a.m. at Government Plaza in Mobile. While not a power-rate proceeding, it’s part of a cluster of environmental infrastructure decisions drawing community scrutiny across Alabama. https://www.fox10tv.com Industry backdrop — Parent company Southern Company recently reported stronger-than-expected third-quarter earnings, citing higher electricity demand—context that helps explain why rate and profit oversight is in the spotlight. Reuters Alabama Power’s bills and the PSC’s playbook A new
10 November 2025
Monday.com (MNDY) Q3 2025 Earnings: Revenue Jumps 26% to $316.9M, EPS $1.16; Stock Whipsaws on Softer Q4 Outlook

Monday.com (MNDY) Q3 2025 Earnings: Revenue Jumps 26% to $316.9M, EPS $1.16; Stock Whipsaws on Softer Q4 Outlook

By the numbers: Q3 FY2025 (ended Sept. 30) Customer & demand metrics Product & platform updates driving the beat Why it matters: A broader product suite and upmarket wins can deepen wallet share and reduce churn, while higher RPO and retention suggest durable demand even as the company calibrates growth versus margins. Business Wire Guidance: Strong growth with a cautious near‑term top line Street context: Ahead of today’s report, consensus centered on $312M revenue and $0.88 EPS for Q3; the company cleared both. The Q4 guide landed below some models—one widely‑cited figure was ~$333–$334M—which helped explain the initial stock downdraft
10 November 2025
·
Archer Aviation (ACHR) Plunges as $650M Equity Raise Funds $126M Hawthorne Airport Deal; Cathie Wood Buys the Dip — What It Means for LA Air Taxis (Nov. 10, 2025)

Archer Aviation (ACHR) Plunges as $650M Equity Raise Funds $126M Hawthorne Airport Deal; Cathie Wood Buys the Dip — What It Means for LA Air Taxis (Nov. 10, 2025)

Archer Aviation’s stock has been hammered over the past few sessions after the eVTOL maker paired a fresh $650 million equity raise with news it will acquire Hawthorne Municipal Airport (Jack Northrop Field) for $126 million in cash to anchor its Los Angeles air‑taxi network. In a high‑profile show of conviction, Cathie Wood’s ARK Invest bought roughly 3 million shares into the sell‑off. Here’s what changed, why shares fell, and what to watch next. GuruFocus+3Business Wire+3 What happened to ACHR stock By the numbers (Q3 2025): Operating expenses $174.8M; net loss $129.9M; Adjusted EBITDA −$116.1M; cash & short‑term investments $1.64B;
10 November 2025
ARCC Stock Today: Ares Capital’s 9.5% Dividend, Q3 Record NAV, and Fresh Insider Buying (Nov. 9, 2025)

ARCC Stock Today: Ares Capital’s 9.5% Dividend, Q3 Record NAV, and Fresh Insider Buying (Nov. 9, 2025)

What’s new on November 9, 2025 By the numbers — Ares Capital’s Q3 2025 snapshot Dividend watch: dates, yield and coverage Insider buying: why it matters CEO Kort Schnabel’s open‑market purchase—13,000 shares for $265,070—adds a tangible vote of confidence from the top. The Form 4 shows prices ranged $20.29–$20.49 on Oct. 31. Insider buys don’t guarantee performance, but they often support sentiment when paired with stable fundamentals and dividend coverage. SEC+1 Valuation check (today) What to watch next Media & analyst chatter you may have missed this week Bottom line For Nov. 9, 2025, the ARCC narrative remains income‑first with
9 November 2025
·
Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Financing & balance sheet: euro notes + tender offer Bristol‑Myers Squibb priced €5 billion in senior unsecured notes across five tranches — €750M 2030 (2.973%), €1.15B 2033 (3.363%), €1.15B 2038 (3.857%), €750M 2045 (4.289%), and €1.2B 2055 (4.581%) — with closing anticipated Nov. 10, 2025. The notes are guaranteed by Bristol‑Myers Squibb Company. Bristol Myers Squibb News Proceeds, plus about $3B in cash, are earmarked to fund BMS’s cash tender offers for multiple outstanding dollar notes. The offers expire Dec. 3, 2025 (early tender Nov. 17), with maximum aggregate purchase prices of $4B (Pool 1) and $3B (Pool 2) excluding
9 November 2025
Viking Therapeutics (VKTX) Today — Nov 9, 2025: New Institutional Buying, Fresh Technical Levels, and Key Catalysts Ahead

Viking Therapeutics (VKTX) Today — Nov 9, 2025: New Institutional Buying, Fresh Technical Levels, and Key Catalysts Ahead

Market snapshot Last close (Fri, Nov 7): $36.77.Intraday range: $34.69 – $37.50; volume: ~4.65M. Why VKTX is back on watch this week 1) Fresh institutional interest and ownership trends Ethos Financial Group’s new position adds to a year when institutions already control roughly three‑quarters of the float. MarketBeat’s automated brief also captures the latest insider activity (including October sales by the CEO and a director), and a blended “Moderate Buy” Street view. While 13F adds don’t guarantee direction, they often increase visibility ahead of catalysts. MarketBeat 2) Technical picture: mixed near‑term, firmer mid‑term Today’s quant readout pegs $35–$38 as the
9 November 2025
1 … 35 36 37 38 39 … 140

Stock Market Today

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop